Clinical Trials Directory

Trials / Sponsors / Neurotech Pharmaceuticals

Neurotech Pharmaceuticals

Industry · 13 registered clinical trials — 1 currently recruiting.

StatusTrialPhaseStarted
RecruitingPhase 4 Study: Long-term Safety and Efficacy of NT-501 in MacTel Type 2, Including Sham Procedure Participants
Macular Telangiectasia Type 2 (MacTel)
Phase 42025-11-21
Active Not RecruitingA Study to Determine the Safety and Efficacy of NT-501 With MHFM
Macular Telangiectasia Type 2
Phase 32025-03-06
CompletedSafety Study to Evaluate Bilateral CNTF Implants in Subjects With MacTel Type 2
Macular Telangiectasia Type 2
Phase 22021-07-21
CompletedA Study to Determine the Safety and Efficacy of NT-501 in Macular Telangiectasia Type 2 - Protocol B
Macular Telangiectasia Type 2
Phase 32018-01-22
CompletedA Study to Determine the Safety and Efficacy of NT-501 in Macular Telangiectasia Type 2 - Protocol A
Macular Telangiectasia Type 2 (MacTel)
Phase 32017-11-24
CompletedExtension Study of NT-501 Ciliary Neurotrophic Factor (CNTF) Implant for Macular Telangiectasia (MacTel)
MacTel (Macular Telangiectasia) Type 2
Phase 22017-05-12
TerminatedStudy of the Intravitreal Implantation of NT-503-3 Encapsulated Cell Technology (ECT) for the Treatment of Rec
Macular Degeneration
Phase 1 / Phase 22014-09-01
CompletedA Phase 2 Multicenter Randomized Clinical Trial of CNTF for MacTel
Macular Telangiectasia Type 2
Phase 22014-04-01
CompletedRetinal Imaging in CNTF -Releasing Encapsulated Cell Implant Treated Patients for Early-stage Retinitis Pigmen
Retinitis Pigmentosa, Usher Syndrome Type 2, Usher Syndrome Type 3
Phase 22012-01-01
CompletedCiliary Neurotrophic Factor (CNTF) Safety Trial in Patients With Macular Telangiectasia (Mactel)
Idiopathic Juxtafoveal Telangiectasia
Phase 12011-05-01
CompletedA Study of Encapsulated Cell Technology (ECT) Implant for Participants With Early Stage Retinitis Pigmentosa
Retinitis Pigmentosa
Phase 22007-01-22
CompletedA Study of Encapsulated Cell Technology (ECT) Implant for Patients With Late Stage Retinitis Pigmentosa
Retinitis Pigmentosa
Phase 22007-01-08
CompletedA Study of an Encapsulated Cell Technology (ECT) Implant for Patients With Atrophic Macular Degeneration
Nonexudative Age-Related Macular Degeneration, Unspecified Eye, Intermediate Dry Stage
Phase 22007-01-05